Established in 2001, and headquartered in Richmond, British Columbia, Canagen Pharmaceuticals Inc. is an innovative and established Canadian generic pharmaceuticals manufacturer actively engaged in the manufacture of finished dosage generic pharmaceuticals, over-the counter (OTC) medication and active pharmaceutical ingredients (APIs) and in the research, development and commercialization of novel drugs covering the cardiovascular, oncology, dementia and anti-viral therapeutic areas.
Canagen Pharmaceuticals Inc. is a subsidiary of the global conglomerate, The Fazio Group of Companies. Established in 1983, The Fazio Group of Companies is a well established and diversified multinational organization, comprising 38 companies, that is actively involved in diverse manufacturing (cooking oil & food products, cosmetics & beauty products, pharmaceuticals, health supplements, environmental products, ship-building, etc), shipping & transportation, bonded-warehousing & distribution, real estate (property) construction & development, international bulk commodities trading, ship-building, hotels, agricultural development, poultry processing, fisheries development, water purification, thermal power plants, mining & processing, pharmaceuticals research & development, biofuels & alternative energy technologies, LED lighting technologies, investment banking, private equity and financial investments. With regional offices and operations in 18 countries (including Canada and China), covering four continents, The Fazio Group employs over 8,800 people worldwide.
Member Since: 2016